# Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers

> **NCT00813670** · PHASE1 · COMPLETED · sponsor: **Xenon Pharmaceuticals Inc.** · enrollment: 64 (estimated)

## Conditions studied

- Healthy Human Volunteers

## Interventions

- **DRUG:** XPF-001

## Key facts

- **NCT ID:** NCT00813670
- **Lead sponsor:** Xenon Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-05
- **Final completion:** 2009-07
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2009-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813670, "Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00813670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*